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1. Introduction 
Since the discovery that dimethylsulfoxide (DMSO) 
induces differentiation of murine Friend erythroleu- 
kemia cells [l] a wide variety of differentiation-pro- 
moting agents have been reported [2-51. 
The aminonucleoside of puromycin, AMS, 
(6dimethyl amino 9 3’-amino 3-deoxyribosyl purine) 
studied as a possible antitumor drug [6] has been 
re-investigated [7]. Low concentrations of AMS 
(10m5 M) promote erythroid differentiation of Friend 
cells without blocking cell multiplication and simul- 
taneous administration of inosine markedly decreases 
the percentage of hemoglobin-producing cells, 
although inosine does not affect the cellular uptake 
of AMS [7]. These data, based on quantitative esti- 
mations of globin messenger RNA, confirm that AMS 
is a very efficient inducer of Friend cell differentiation 
and demonstrate that the inhibitory effect of inosine, 
involves quantitative regulation of specific mRNA. 
2. Materials and methods 
2 .l . Cell culture 
Friend erythroleukemia cells (clone 745-A) were 
cultivated in the absence or presence of AMS alone 
(5 pg/ml) or AMS plus inosine as in [7]. In some 
experiments, higher concentrations of inosine 
(<IO0 pg/ml) were utilized because of variations in 
the efficiency of different inosine batches. Cells were 
collected on day 4 of treatment when the total num- 
ber of cells and the percentage of differentiated cells 
reach a maximum. 
2.2. Preparation of cellular RNA 
Total cytoplasmic RNA was extracted from the 
postmitochondrial supernatant of cells lysed with 
Nonidet P40 and cleared from DNA and tRNA by 
precipitating in 2 M LiCl. 
2.3. Isolation of globin mRNA and synthesis of 
glo bin cDNA 
Total RNA was prepared from reticulocytes of 
phenylhydrazine-treated Swiss mice using methods in 
[8] and polyadenylated 9 S globin mRNA was puri- 
fied by two successive passages through oligo(dT) 
cellulose columns followed by sucrose gradient cen- 
trifugation. The highly radioactive globin cDNA 
probe was cell-free synthetised in optimal conditions 
[9] using 2 1.18 9 S globin mRNA and dc[3H]Tp (23 
Ci/mmol) at 8 .lO” M. It was further characterized 
by alkaline sucrose gradient centrifugation which 
showed peak fractions sedimenting at 5-7 S and 
hybridization to a mixture of DNA from PCRla 
H4 and PCRr /3H, plasmids carrying the mouse DNA 
sequences that encode the (Y and /J globin chains, 
respectively [lo]. The plasmid DNA preparations 
were a gift from F. Rougeon. 
2.4. Hybridization assays 
All solutions and containers were pretreated with 
0.2% diethylpyrocarbonate. Annealing assays were 
performed at 68’C in 0.4 M NaCl, 0.01 M Tris buffer 
(pH 7.4) 0.01 M EDTA, 0.2% SDS and the percent- 
ages of cDNA hybridized were determined by the use 
of Sr nuclease as in [I I]. 
22% ElsevierlNorth-Holland Biomedical Press 
Volume 114, number 2 FEBS LETTERS June 1980 
t 
-5 -4 -3 -2 -1 -4-3-2-l 0 lfil 
I .I a, ., 8, .1 .t 
LOG Rot 
Fig.1. (A) Hybridization of c[ 3H]DNA probe with 9 S globin 
RNA (Rot,,, = 3.5 . lo-‘). (B) Hybridization of c[~H]DNA 
probe with plasmid DNA carrying the globin DNA sequences. 
(I) Log Cot. Co, initial concentration of DNA plasmid 
(Cot,,, 3.6 . lo-‘). (II) Corrected Log Cot. Co, initial concen- 
tration of globin sequences contained in plasmid DNA (-5%) 
(Cotl,, 1.8. 1O-3). 
3, Results and discussion 
Following alkaline gradient centrifugation, most of 
the cell-free synthesised c[~H]DNA molecules edi- 
mented at 5-7 S (not shown), which indicated they 
represented copies of the largest portion or all of the 
globin RNA template. Also the greatest part of 
c[~H)DNA could be reassociated to 9 S RNA (fig.lA) 
or plasrnid DNA carrying the globin DNA sequences 
(fig.lB). Furthermore when the C,t values calculated 
for the total amounts of recombinant plasmid DNA 
were corrected, according to their globin DNA 
content, the hybridization kinetics of c[~H]DNA 
appeared faster with plasmid DNA than with 9 S RNA 
(Cotl,?, = 1.8 . 10e3 and RorvZ = 3.5 . 1 0W3 respec- 
tively). Since the recombinant DNA contained no 
other mouse DNA sequences than those of the globin 
genes, this result is good indication that both the 9 S 
RNA and the cDNA probe used here were essentially 
globin specific. 
Typical hybridization curves between globin 
ct3HJDNA and total cytoplasmic RNA from induced 
or non-induced Friend cells are shown in fig.2. Only a 
small part of the radioactive probe could be reas- 
sociated to RNA from non-induced cells. This is con- 
sistent with the low proportion of benzidine positive 
cells (l-3%) which is found in control cultures. In 
contrast he greatest portion of globin cDNA hybrid- 
ized very much faster to RNA from all AMS-induced 
cells, but at significantly slower ates to RNA from 
cells treated with inosine plus AMS, than to RNA 
from cells treated with AMS alone. The table gives 
the Ror,,, values derived from these curves and the 
corresponding globin RNA contents. As seen, AMS- 
treated cells appeared to contain an average of 
17 000-l 8 000 globin RNA molecules~cell. In 
comparison DMSO treated cells contained 10 OOO- 
14 000 globin mRNAs according to [ 12-141 and 
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Fig.2. Hybridization of globin c[“H]DNA with cytoplasmic 
RNA from Friend cells treated with: AMS (*---+); AMS + 
inosine (10 #g/ml) (e----=1; AMS + inosine (100 ~~rnl) 
(*---0); non-induced cells (O-O). 
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Table 1 
Inhibitory effects of inosine on erythroi’d differentiation induced by AMS 
Treatment of cells % Differentiated 
cells 
(Benzidine positive) 
Globin cDNA % Globin mRNA Mean number Inhibition index 
hybridized to in cellular RNA of globin mRNA - 
cellular RNA sequences/cell I II 
Rot,,, 
AMS 5 pg/ml 80 2.6 0.135 17 400 _ _ 
id + inosine lOpg/ml 25 7.0 0.05 6200 3.2 2.8 
100 fig/ml 15 17.0 0.02 2600 5.3 6.6 
The percentages of globin mRNA were calculated from the ratios of the indicated Rot,,, values to the Rot,,, obtained with glo- 
bin cDNA hybridized to purified globin mRNA and the mean numbers of globin mRNA sequences were derived from these per- 
centages. Inhibition index: I, percentage benzidine positive cells with AMS alone/percentage benzidine positive cells with AMS + 
inosine; II, mean number of globin one RNA sequences with AMS alone/mean umber of globin mRNA sequences with AMS + 
inosine. The average cell RNA content was -4.2 pg in all experiments and was the same for cells treated with AMS alone or AMS 
plus inosine 
9000-10 000 according to us (not shown). This 
degree of abundance confirms that AMS is a potent 
inducer of erythroi’d differentiation in this cell sys- 
tem. Finally, it is interesting to note that despite some 
variations in the efficiency of different inosine 
batches, the globin mRNA content always decreased 
in about the same proportion as the percentage of 
hemoglobin producing cells, in induced cell cultures 
subjected to inosine. This allows the conclusion that 
inhibition of Ah4S-induced differentiation by inosine, 
appears to involve quantitative regulation of specific 
mRNAs at either the transcriptional or post-transcrip- 
tional level or both. 
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